Endogenex

Plymouth, MN · Founded 2017 · Privately Held (backing)

Developer of a medical device system designed to improve metabolic function in individuals with diabetes by resetting metabolic signalling in the small intestine. Endogenex is based in Plymouth, MN and was founded in 2017. It was valued at $218 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $190 million across 3 recorded rounds; the latest was a $69.6 million later-stage round in Jun 2024.

PMV mark · valuation
$218.0M
Oct 2026
Priced at
its later-stage round
Mar 2026
Total raised
$190.4M
Last round
Later Stage VC
Jun 2024

Who backs Endogenex?

11 investors
InvestorType
Hatteras Venture PartnersVenture capital
Mayo Clinic Ventures—
Arboretum VenturesVenture capital
Longitude CapitalVenture capital
Fourth Element Capital—
Intuitive Ventures—
John Deedrick—
Lumira Ventures—
Orlando Health Ventures—
Santé Ventures—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Endogenex investors

11 investors are on record for Endogenex, including Hatteras Venture Partners, Mayo Clinic Ventures, Arboretum Ventures and Longitude Capital. The later-stage round in Jun 2024 drew 11 investors.

Free account
More of Endogenex with a free account
  • ·The complete investor list: 11 names
  • ·Watch Endogenex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Endogenex. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View